MedPath

Heart Failure and Hemodynamic Stability During Anesthesia Induction

Not Applicable
Completed
Conditions
Hemodynamic Instability
Diastolic Dysfunction
Anesthesia; Adverse Effect
Venous; Return (Anomaly)
Heart Failure
Interventions
Other: Preoperative colloid fluid bolus (Gelofusine)
Diagnostic Test: Preoperative transthoracic echocardiography
Registration Number
NCT03576261
Lead Sponsor
Umeå University
Brief Summary

The study aim is to investigate whether preoperative heart failure has impact on hemodynamic stability during anesthesia induction by target controlled infusion of anesthesia (TCI) in non-cardiac, non-morbidly obese surgery.

Detailed Description

40 individuals are enrolled to the study after signed informed consent at the day of surgery. The study participants are randomized (non-blinded) to preoperative fluid therapy (preoperative colloid fluid bolus at 6 ml/kg LBW, Gelofusine™, Fresenius Kabi AB, Sweden) or control (no preoperative fluids) before standardized TCI- induction of anesthesia. No other intravenous fluids before anesthesia induction.

Preoperative screening of biventricular systolic and diastolic function of the heart and level of venous return is implemented by transthoracic echocardiography approximately one hour before preoperative fluid therapy and anesthesia induction.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
44
Inclusion Criteria
  • age over 18 years
  • body mass index ≤ 35 kg/m2
  • electively scheduled for breast cancer surgery, endocrinologic surgery (thyroid, parathyroid) and general abdominal surgery
Exclusion Criteria
  • instable angina pectoris
  • severe bronchial asthma
  • severe COPD
  • dementia
  • severe heart valve disease
  • severe renal failure
  • body mass index > 35 kg/m2

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Preoperative echo + fluidsPreoperative transthoracic echocardiography20 individuals investigated by preoperative transthoracic echocardiography. Preoperative colloid fluid bolus (Gelofusine, Fresenius Kabi AB, Sweden) 6 ml/kg lean body weight, is infused intravenously immediately before anesthesia induction.
Preoperative echo + fluidsPreoperative colloid fluid bolus (Gelofusine)20 individuals investigated by preoperative transthoracic echocardiography. Preoperative colloid fluid bolus (Gelofusine, Fresenius Kabi AB, Sweden) 6 ml/kg lean body weight, is infused intravenously immediately before anesthesia induction.
Preoperative echo, controlPreoperative transthoracic echocardiography20 individuals investigated by preoperative transthoracic echocardiography. No intravenous fluids are infused before anesthesia induction.
Primary Outcome Measures
NameTimeMethod
Incidence of severe blood pressure drops20 minutes post anesthesia induction

Blood pressure drop below mean arterial pressure at 55 mmHg during anesthesia induction. Non-invasive blood pressures (systolic, mean and diastolic) are measured 5 minutes before anesthesia induction and thereafter every 5 minutes post-induction.

Incidence of blood pressure drops20 minutes post anesthesia induction

Blood pressure drop below mean arterial pressure at 65 mmHg during anesthesia induction. Non-invasive blood pressures (systolic, mean and diastolic) are measured 5 minutes before anesthesia induction and thereafter every 5 minutes post-induction .

Secondary Outcome Measures
NameTimeMethod
Diastolic dysfunction and hemodynamic stability20 minutes post anesthesia induction

Diastolic dysfunction impact on blood pressure drops during anesthesia below mean arterial pressure at 65 mmHg

Venous return and hemodynamic stability20 minutes post anesthesia induction

Level of venous return impact on blood pressure drops during anesthesia below mean arterial pressure at 65 mmHg

Systolic heart failure and hemodynamic stability20 minutes post anesthesia induction

Systolic heart failure impact on blood pressure drops during anesthesia below mean arterial pressure at 65 mmHg

Trial Locations

Locations (1)

Sunderby teaching hospital

🇸🇪

Luleå, Sweden

© Copyright 2025. All Rights Reserved by MedPath